BioSpace News Archive

Roche announced the expansion of their Global Business Partnership Agreement with Sysmex.

Bavarian Nordic A/S announced that the U.S. Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, has placed a new order valued at USD 120 million, primarily covering the manufacturing of new bulk product for the Company’s smallpox/mpox vaccine.

Scientists at the Research Center for Materials Nanoarchitectonics have developed micrometer-sized “liquid marbles” that can encapsulate single to several living cells, thereby aiding single-cell studies.

Kyverna Therapeutics announced the close of an oversubscribed $60 million Series B financing round extension, bringing the total Series B financing round to $145 million.

Jin Medical International Ltd. which is the world’s leading provider of rehabilitation equipment.

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2024 first quarter that ended June 30, 2023.

Affimed N.V. announced that it will release second quarter 2023 results and corporate update on Thursday, August 10, 2023.

Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended July 2, 2023.

Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism pioneering therapies for rare diseases, reported business highlights and financial results for the second quarter ended June 30, 2023.

BD, a leading global medical technology company, announced results for its third quarter of fiscal 2023, which ended June 30, 2023.